S.L. reports research funding (to institution) from Amgen, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Daichii Sankyo, Hutchinson, Incyte, Merck Serono, Mirati, MSD, Pfizer, Roche and Servier; personal honoraria as an invited speaker from Amgen, Bristol-Myers Squibb, Incyte, GSK, Lilly, Merck Serono, MSD, Pierre-Fabre, Roche and Servier; and participation in advisory board for Amgen, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GSK, Incyte, Lilly, Merck Serono, MSD, Servier and Takeda. F.P. reports research funding (to institution) from Lilly, BMS, AstraZeneca, Incyte, Amgen and Agenus; personal honoraria as an invited speaker from Amgen, Merck-Serono, BMS, Servier, Bayer, Pierre-Fabre, Takeda, Ipsen and Astellas; and participation in advisory board for Amgen, Merck-Serono, MSD, Bayer, Organon, Astellas, Takeda, Servier and GSK.